Taunton Surgical Center

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Crohn's disease3 trials
• Ulcerative colitis1 trial

Phase

• Phase 42 trials

Status

• Recruiting2 trials
• Completed1 trial

Lead sponsor

• Alimentiv Inc.1 trial
• TIDHI Innovation Inc.1 trial
• University of Calgary1 trial

Running trials

• Recruiting

  Switching to the IL-23 Inhibitor Guselkumab for People With Active IBD Who Previously Used Ustekinumab (SHIFT-IBD)

  NCT07245394· TIDHI Innovation Inc.· Source

  Contact: Alana Carter, BSN, MN

• Recruiting

  PATHFINDER: Evaluating the Optimal First-Line Treatment Strategy for Moderate-to-Severely Active Ileal-dominant Crohn's Disease

  NCT05928039· Phase 4· University of Calgary· Source

  Contact: Daniel Green, MD (principal investigator)

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Crohn's disease2 recruiting
• Ulcerative colitis1 recruiting

Closed trials

• Completed

  Stopping Aminosalicylate Therapy in Inactive Crohn's Disease

  NCT03261206· Phase 4· Alimentiv Inc.· Source